| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 271.86▼ | 272.92▼ | 272.07▼ | 274.42▼ | 266.48▲ |
| MA10 | 272.41▼ | 272.20▼ | 272.98▼ | 273.79▼ | 267.75▲ |
| MA20 | 272.94▼ | 272.98▼ | 273.60▼ | 267.62▲ | 233.99▲ |
| MA50 | 272.16▼ | 273.94▼ | 272.90▼ | 264.81▲ | 191.61▲ |
| MA100 | 272.64▼ | 272.96▼ | 272.19▼ | 228.26▲ | 197.16▲ |
| MA200 | 273.39▼ | 271.52▼ | 268.18▲ | 196.09▲ | 181.80▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.254▼ | 0.018▲ | -0.307▼ | 0.021▲ | 1.591▲ |
| RSI | 37.221▼ | 43.513▼ | 42.907▼ | 53.506▲ | 66.844▲ |
| STOCH | 10.230▼ | 64.309 | 52.855 | 62.547 | 60.001 |
| WILL %R | -100.000▼ | -52.609 | -52.609 | -39.820 | -28.298 |
| CCI | -126.667▼ | -32.416 | -67.588 | -44.836 | 72.675 |
|
Monday, September 30, 2024 08:15 AM
US RNAi therapeutics company Alnylam Pharmaceuticals has released two new data sets from the HELIOS-B Phase III study of Amvuttra (vutrisiran), an investigational RNAi therapeutic in development for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/10/24 | 275.62 | 275.62 | 264.84 | 271.55 | 541,489 |
| 01/10/24 | 274.88 | 277.94 | 268.13 | 276.06 | 601,500 |
| 30/09/24 | 275.50 | 277.84 | 272.55 | 275.03 | 786,739 |
| 27/09/24 | 275.50 | 276.07 | 271.48 | 274.91 | 459,500 |
| 26/09/24 | 271.84 | 278.24 | 270.83 | 274.57 | 548,800 |
| 25/09/24 | 271.61 | 275.11 | 268.34 | 272.73 | 680,100 |
| 24/09/24 | 271.56 | 271.66 | 267.13 | 271.00 | 489,600 |
| 23/09/24 | 275.22 | 275.74 | 270.97 | 271.83 | 571,400 |
| 20/09/24 | 275.39 | 275.39 | 270.17 | 273.88 | 902,002 |
| 19/09/24 | 276.53 | 279.85 | 273.53 | 276.33 | 603,900 |
|
|
||||
|
|
||||
|
|